Clinical Trial to Compare the Pharmacokinetics and Pharmacodynamics After Oral Administration of Glucophage and HL-018

NCT01232036 ↗

Phase 1 Completed 28 enrolled Asan Medical Center HanAll BioPharma Co., Ltd. · collab

RandomizedCrossoverOpen-labelSupportive care

Summary

This study is designed to to compare the pharmacokinetic and pharmacodynamic characteristics and safety after oral administration of Glucophage with those after oral administration of HL-018 in healthy male volunteers

Timeline

Start: 2010-05
Primary completion: 2010-08
Completion: 2010-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HL-018	Unknown	500 mg	Oral
Comparator	Metformin	Small molecule	500 mg	Oral

Indications

No indication recorded.